From 20 17 to 202 1, Yaben's share price fluctuated around 6 yuan for five years, reaching a high level!
In the last three years, there has been a super main force lurking in it, and the main force has been highly controlled.
Second, the analysis of the trend of skyrocketing and plunging in the past three months
After the opening of the seventh day of the first month, the main force did not hesitate. One day hit the daily limit and then plunged for four days. * * * fell by 44%, from the height of 44%, which means that it still needs 88% to reach the previous high. Cruel! The lowest fell to 14.6 yuan, and the panic filled Yaben Group, scrambling to flee. Fang 22 yuan lost1.1.30 million, and still holds more than 90 million. Ge Weidong 1.5 yuan still holds1.60 million. Judging from the distribution of chips, most of the chips at the bottom profit and flee.
On February 1 1 in 2022, Boteng announced that it had received a large bill of US$ 68 1 10,000 from Pfizer, which was inextricably linked with paciclovir. On the second trading day, February 14, the opening 10 minute, Yaben continued to attack and packed lightly.
This year's target is 522 yuan -600 yuan.
Third, quiet, boring and rich Yaben should appear.
In the past three months, Yaben has been taciturn, talking less and doing more, quietly, and made a fortune.
The CSRC doesn't ask, don't tell, and don't introduce in depth, giving people a feeling of being honest, not causing trouble, and not rubbing hot spots.
Yaben, show your cards!
Four. Review of yaben events
(1) Composition of the aircraft carrier Yaben
Yaben has six bases, three R&D centers, two satellite companies, two environmental protection businesses, a subsidiary of Abino pharmaceutical and health products company in the United States, and nearly 20 partners around the world. (See the layout blueprint of Yaben Aba Empire for details. )
(2) Purchase carbonic anhydride patents
20 1 1, 500,000 yuan was purchased for the patent of carotene anhydride produced by Shanghai North Carolina Pharmaceutical Company, and the annual production capacity of 240 tons was built in 20 12, which was used to produce the intermediate carotene anhydride of bosivir for hepatitis C. Later, the drug was not recommended by WHO because of its side effects. Yaben can't change the production line to produce pesticide intermediates on 20 14, and keep the annual production capacity of 30 tons of caron anhydride to produce a small amount of Bosaviv drugs.
(III) Acquisition of Malta ACL, a subsidiary of CDMO
20 100% equity of Malta ACL Company was purchased at 24.458 million euros (about1800,000 RMB) on May 6, 2007, and all the equity of ACL Company was acquired after the equity delivery. ACL is the first well-known generic drug CDMO company in Europe. It has more than 20 years of CDMO experience and holds FDA certification.
(D) The establishment of Sun Company
2065438+On June 8, 2009, Sun Company was established to produce cannabidiol CBD with an annual output of 700kg. It is expected to be mass-produced in 2023.
(V) Layout of satellite companies
1. Hubei Xiangyang Yuchang Fine Chemical Co., Ltd., with the layout of Yaben 201919, holding 18%.
On June 5438+1October 65438+February 2022, the project with an annual output of 500 tons of carrot anhydride was declared;
On June 28th, 2022, 65438+20221October 28th, 2022, the project with an annual output of 300 tons of intermediate 549 was declared.
2. Liaoning Fuxin Fulongbao Pharmaceutical Technology Co., Ltd., laid out by Yaben on March 9, 2020, holds 20% of the shares.
(6) The production line of pesticide intermediates was changed to produce carotene.
In September of 20021year, the market was snapped up, and Yaben keenly discovered business opportunities. After research, he immediately invested 6.9 million yuan to transform this production line into a pesticide intermediate for the production of carotene. In June, 1 1.4, it was announced that Yaben would produce 20 tons of carotene anhydride/month.
(7) Apply for patent 77 1 for pharmaceutical advanced intermediates.
202 1 65438+2 2 1, Yabo Company Shanghai Puyi Chemical Technology Co., Ltd. has formally applied for the patent of advanced intermediate 77 1.
(8) Declare 50 tons of Palovid API.
June 5438+1October 65438+1October 7, 2022, the 50-ton Palovic API project was declared and approved.
(9) On February 2, 2022, China urgently approved the import of oral drugs from Pfizer COVID-19.
6. Yaben, show your cards! Show your killer! Ideal production capacity in 2022
1. carbonic anhydride production capacity
240+120+500+500 =1360 tons
2. Production capacity of advanced intermediates 77 1
680 tons
3. The production capacity of Pfizer's oral drug Palovic.
50 tons
4. Pfizer authorized ACL first imitation drug
very likely/probably
5.A2W produces marijuana.
Mass production in 2023
6. Pesticides and intermediates
7. Environmental protection
8. Longevity health care NMN and AKG